The Radiation Oncology Department Research Unit at Hôpital Maisonneuve-Rosemont emphasizes innovation and collaboration. The unit’s 15 radiation oncologists have a wide range of expertise in all types of cancer and are particularly interested in optimizing stereotactic body radiation therapy (SBRT) as well as hypofractionated radiotherapy and radiosensitizers.
Integrative medicine is part of the future, which is why the team’s research also focuses on patient services, such as PAROLE-Onco with the CROIRE program.
The Radiation Oncology Department at Hôpital Maisonneuve-Rosemont Radiation uses state-of-the-art techniques to deliver intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT) and stereotactic body radiation therapy (SBRT), which target cancer cells down to the millimetre while sparing healthy organs. Our technologists precisely deliver treatments using cone-beam computed tomography (CBCT) for daily positioning verification.
Using magnetic resonance planning for endocavitary and interstitial treatments, the unit’s brachytherapy division is one the most innovative curative, adjuvant and intraoperative facilities in the country. The radiological physics team deploys progressive dosimetric strategies in addition to studying advanced imaging, modelling, and new delivery techniques while ensuring patient safety.
With recruitment ongoing for over 15 active clinical protocols, the team is constantly looking for more optimal ways to care for its patients.